Optimal Management of Severe Plaque Form of Psoriasis

David Fairhurst; Darren M. Ashcroft; Christopher Em Griffiths

doi:10.2165/00128071-200506050-00002

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2005

Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks

Luigi Naldi, Christopher Em Griffiths

Article2012

Does p40‐targeted therapy represent a significant evolution in the management of plaque psoriasis?

Christopher Em Griffiths, Giampiero Girolomoni

Article2014

Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial

Robert Bissonnette, Lars Iversen, Howard Sofen, Christopher Em Griffiths, Peter Foley, Ricardo Romiti, Mary Bachinsky, S.T. Rottinghaus, Huaming Tan, James Proulx, Hernán Valdez, Pankaj Gupta, Lotus Mallbris, Robert Wołk

Letter2013

Alemtuzumab and chronic plaque psoriasis

Aamir Aslam, Alexander Marsland, David Rog, Christopher Em Griffiths

Article2023

Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Alexander Egeberg, Joseph F. Merola, Knut Schäkel, L. Puig, Patrick Mahar, Isabella Yali Wang, Imre Pávó, Christopher Schuster, Christopher Em Griffiths